High-dose-rate brachytherapy in lower eyelid cancer.
To evaluate the feasibility of high-dose-rate (HDR) brachytherapy in eyelid tumors. No previous reports on HDR brachytherapy for eyelid cancer are found in the literature. An individual case is reported. A detailed description of the implantation technique, dose prescription, and treatment delivery is provided. The implantation and the treatment course were uneventful. Short-term tolerance was within normal limits. HDR brachytherapy can be used in patients with eyelid cancer. The larger diameter of HDR applicators compared to LDR wires do not preclude the use of HDR brachytherapy in this structure.